Immunoprophylactic failure against hepatitis B virus mother-to-infant transmission from 2018 to 2023

Recruiting

• Conditions: Mater to child viral hepatitis B transmission; MTCT, HBV

• Registration Number: TCTR20240401001
• Lead Sponsor: /A

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-04-01
• Last Update Posted: 19 August 2024
• Study Completion: 2024-12-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

All children of hepatitis B surface antigen (HBsAg) seropositive mothers with known HBeAg status

Exclusion Criteria

children of hepatitis B surface antigen (HBsAg) seropositive mothers with unknown HBeAg status

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
the prevalence and factors associated with the failure of immunoprophylactic Hepatitis B vaccines. 5 years Hepatitis B virology of the child measurment at 9-12 months

Secondary Outcome Measures

Name	Time	Method
/A N/A N/A